Plasma Cell Generation by IL-21, a Novel Regulation of B Cell Differentiation and
暂无分享,去创建一个
P. Lipsky | W. Leonard | Chen-feng Qi | Hyoung-Pyo Kim | S. Akilesh | D. Roopenian | H. Morse | Rosanne Spolski | R. Ettinger | D. Shaffer | Gang Wang
[1] S. Pillai,et al. Marginal zone B cells. , 2005, Annual review of immunology.
[2] N. Sarvetnick,et al. Homeostatic Expansion of T Cells during Immune Insufficiency Generates Autoimmunity , 2004, Cell.
[3] M. Scott,et al. Cutting Edge: BAFF Regulates CD21/35 and CD23 Expression Independent of Its B Cell Survival Function , 2004, The Journal of Immunology.
[4] W. Leonard,et al. In vivo antitumor activity of interleukin 21 mediated by natural killer cells. , 2003, Cancer research.
[5] C. Tunyaplin,et al. Regulatory mechanisms that determine the development and function of plasma cells. , 2003, Annual review of immunology.
[6] S. Akilesh,et al. Customized molecular phenotyping by quantitative gene expression and pattern recognition analysis. , 2003, Genome research.
[7] M. Collins,et al. IL-21 Induces the Apoptosis of Resting and Activated Primary B Cells1 , 2003, The Journal of Immunology.
[8] Kotaro Suzuki,et al. Interleukin 21 prevents antigen-induced IgE production by inhibiting germ line Cε transcription of IL-4–stimulated B cells , 2002 .
[9] A. Sher,et al. A Critical Role for IL-21 in Regulating Immunoglobulin Production , 2002, Science.
[10] Liming Yang,et al. Blimp-1 orchestrates plasma cell differentiation by extinguishing the mature B cell gene expression program. , 2002, Immunity.
[11] A. Waage,et al. Interleukin-21 is a growth and survival factor for human myeloma cells. , 2002, Blood.
[12] M. Collins,et al. IL-21 limits NK cell responses and promotes antigen-specific T cell activation: a mediator of the transition from innate to adaptive immunity. , 2002, Immunity.
[13] S. Shinton,et al. Resolution of Three Nonproliferative Immature Splenic B Cell Subsets Reveals Multiple Selection Points During Peripheral B Cell Maturation1 , 2001, The Journal of Immunology.
[14] W. Leonard. Cytokines and immunodeficiency diseases , 2001, Nature Reviews Immunology.
[15] K. Rajewsky,et al. Homeostasis of Peripheral B Cells in the Absence of B Cell Influx from the Bone Marrow , 2001, The Journal of experimental medicine.
[16] I. Berberich,et al. Blimp‐1 over‐expression abrogates IL‐4‐ and CD40‐mediated suppression of terminal B cell differentiation but arrests isotype switching , 2001, European journal of immunology.
[17] H. Asao,et al. Cutting Edge: The Common γ-Chain Is an Indispensable Subunit of the IL-21 Receptor Complex1 , 2001, The Journal of Immunology.
[18] D. Fearon,et al. Suppression of Signal Transducer and Activator of Transcription 3–Dependent B Lymphocyte Terminal Differentiation by Bcl-6 , 2000, The Journal of experimental medicine.
[19] K. Calame,et al. BLIMP-1 mediates extinction of major histocompatibility class II transactivator expression in plasma cells , 2000, Nature Immunology.
[20] Scott R. Presnell,et al. Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function , 2000, Nature.
[21] W. Leonard,et al. Cloning of a type I cytokine receptor most related to the IL-2 receptor beta chain. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[22] K. Toellner,et al. Intrinsic Constraint on Plasmablast Growth and Extrinsic Limits of Plasma Cell Survival , 2000, The Journal of experimental medicine.
[23] Dexi Liu,et al. Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA , 1999, Gene Therapy.
[24] P. Sideras,et al. B Cell Development in the Spleen Takes Place in Discrete Steps and Is Determined by the Quality of B Cell Receptor–Derived Signals , 1999, The Journal of experimental medicine.
[25] R. Siegel,et al. Mature T lymphocyte apoptosis--immune regulation in a dynamic and unpredictable antigenic environment. , 1999, Annual review of immunology.
[26] W. Paul,et al. The IL-4 receptor: signaling mechanisms and biologic functions. , 1999, Annual review of immunology.
[27] Mark M. Davis,et al. Differential Effect of B Lymphocyte–induced Maturation Protein (Blimp-1) Expression on Cell Fate during B Cell Development , 1998, The Journal of experimental medicine.
[28] D. Cado,et al. Transgenic expression of the Ly49A natural killer cell receptor confers class I major histocompatibility complex (MHC)-specific inhibition and prevents bone marrow allograft rejection , 1996, The Journal of experimental medicine.
[29] Mark M. Davis,et al. Blimp-1, a novel zinc finger-containing protein that can drive the maturation of B lymphocytes into immunoglobulin-secreting cells , 1994, Cell.
[30] H. Pircher,et al. T cell tolerance to Mlsa encoded antigens in T cell receptor V beta 8.1 chain transgenic mice. , 1989, The EMBO journal.
[31] D. Wofsy. Administration of monoclonal anti-T cell antibodies retards murine lupus in BXSB mice. , 1986, Journal of Immunology.
[32] J. Roths,et al. A Y chromosome associated factor in strain BXSB producing accelerated autoimmunity and lymphoproliferation. , 1979, Arthritis and rheumatism.